Randomized, Double Blind Evaluation of Sequential Administration of gp120 B/E (AIDSVAX B/E) (GSID) With 1-Year Boosting in HIV-uninfected Thai Adults
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs HIV gp120 vaccine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 12 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 02 May 2017 Planned End Date changed from 1 Feb 2017 to 1 Feb 2018.